| Preface | p. vii |
| Acknowledgments | p. ix |
| Contributors | p. xi |
| Introduction | p. 1 |
| Neural and Neuroendocrine Mechanisms in Host Defense: Molecular and Cellular Mechanisms | p. 5 |
| Stress-induced Changes in Immune Cell Distribution and Trafficking: Implications for Immunoprotection versus Immunopathology | p. 7 |
| Introduction | p. 7 |
| Stress | p. 9 |
| Stress-induced Changes in Blood Leukocyte Numbers | p. 9 |
| Hormones Mediating Stress-induced Changes in Blood Leukocyte Numbers | p. 10 |
| A Stress-induced Decrease in Blood Leukocyte Numbers Represents a Redistribution Rather Than a Destruction or Net Loss of Blood Leukocytes | p. 12 |
| Target Organs of a Stress-induced Redistribution of Blood Leukocytes | p. 13 |
| Acute Stress-induced Changes in Blood Leukocyte Numbers: Contradicting Results or a Biphasic Response? | p. 14 |
| Stress-induced Redistribution of Blood Leukocytes: Molecular Mechanisms | p. 16 |
| Stress-induced Redistribution of Blood Leukocytes: Functional Consequences | p. 16 |
| Conclusion | p. 18 |
| References | p. 19 |
| Stress-induced Sympathetic Nervous System Activation Contributes to Both Suppressed Acquired Immunity and Potentiated Innate Immunity: The Role of Splenic NE Depletion and Extracellular Hsp72 | p. 26 |
| Introduction | p. 26 |
| Excessive Sympathetic Nervous System Output Is Detrimental to Health | p. 27 |
| Stress Modulates Immune Function: Acquired versus Innate | p. 27 |
| Animal Model of Acute Stress | p. 28 |
| Stress Suppresses Acquired Immunity | p. 28 |
| In Vivo Generation of Antibody Against KLH Is a Measure of Acquired Immunity | p. 28 |
| The Spleen Is Site for Stress-induced KLH Antibody Suppression | p. 29 |
| Cellular Mechanisms of Stress-induced KLH Antibody Suppression | p. 29 |
| Excessive Sympathetic Nervous System Response Suppresses Acquired Immunity | p. 30 |
| Summary | p. 33 |
| Stress Facilitates Innate Immunity | p. 33 |
| Introduction | p. 33 |
| Subcutaneous Bacterial Challenge Is a Measure of Innate Immunity | p. 34 |
| Stress Facilitates Recovery from Subcutaneous E. coli Challenge: A Role for NO | p. 35 |
| Stress and Extracellular Heat Shock Proteins | p. 36 |
| Introduction | p. 36 |
| Intracellular Heat Shock Proteins | p. 36 |
| Extracellular Heat Shock Proteins | p. 36 |
| Stress-induced Sympathetic Nervous System Output Stimulates eHsp72 Release | p. 37 |
| Necrosis- versus Exocytosis-Mediated Release | p. 37 |
| eHsp72 Release Involves Norepinephrine and [Alpha subscript 1]ADRs | p. 38 |
| Immunostimulatory Effect of Extracellular Hsp72 | p. 39 |
| Extracellular Hsp72 and the Danger Theory | p. 39 |
| Innate Immune Cell Activation: Toll-like Receptors Bind eHsp72 | p. 40 |
| Stress Facilitates Recovery from Subcutaneous E. coli Challenge: A Role for eHsp72 | p. 41 |
| Summary | p. 42 |
| General Conclusions | p. 43 |
| References | p. 44 |
| Anthrax Lethal Factor Represses Glucocorticoid and Progesterone Receptor Activity | p. 57 |
| Introduction | p. 57 |
| Hypothalamic-Pituitary-Adrenal Axis and Glucocorticoid Responses | p. 57 |
| Protective Features of an Intact HPA Axis and Glucocorticoid Response | p. 59 |
| Diminished HPA Axis and GR Responses in Disease | p. 60 |
| Anthrax Lethal Toxin | p. 62 |
| Anthrax Lethal Toxin Repression of GR | p. 66 |
| p38 MAPK and GR | p. 67 |
| Therapeutic Implications | p. 68 |
| References | p. 69 |
| Adrenergic Regulation of Adaptive Immunity | p. 81 |
| Introduction | p. 81 |
| Sympathetic Innervation of Lymphoid Tissue and Norepinephrine Release | p. 81 |
| Initial Evidence That Norepinephrine Plays a Role in Regulating Adaptive Immune Cell Activity | p. 83 |
| Receptors for Adrenergic Receptors on Adaptive Immune Cells | p. 86 |
| Effect of Norepinephrine and [Beta subscript 2]-Adrenergic Receptor Stimulation on Adaptive Immune Cell Activity | p. 88 |
| Summary | p. 93 |
| References | p. 94 |
| Gender Dimorphism and the Use of Sex Steroid/Receptor Antagonist After Trauma | p. 101 |
| Introduction | p. 101 |
| Gender Dimorphism in Trauma Patients | p. 101 |
| Sex Hormones and Response to Experimental Trauma | p. 103 |
| Sex Hormones and Immune Response to Trauma | p. 103 |
| Sex Hormones and Alterations in Cardiac Function | p. 105 |
| Sex Hormones and Alterations in Hepatocellular Function | p. 106 |
| Sex Hormones and Mortality in Animals After Trauma-Hemorrhage from Subsequent Sepsis | p. 106 |
| Sex Hormone Receptors | p. 107 |
| Use of Male Sex Hormone Receptor Antagonist | p. 107 |
| Use of Female Sex Hormone Receptor Antagonist | p. 108 |
| Synthesis of Sex Steroids | p. 108 |
| Use of Inhibitors of Sex Steroid Synthesis | p. 111 |
| Use of Sex Steroid Metabolites as Therapeutic Regimens After Trauma-Hemorrhage | p. 112 |
| Additional Target for the Modulation of Sex Hormones and Their Influence on Post-Trauma Organ Functions | p. 113 |
| Conclusion | p. 114 |
| References | p. 114 |
| Neural and Neuroendocrine Mechanisms in Host Defense: Physiological Effects of Stress on Host Susceptibility to Infection and Autoimmunity | p. 123 |
| The Impact of Psychological Stress on the Immune Response to and Pathogenesis of Herpes Simplex Virus Infection | p. 125 |
| Introduction | p. 125 |
| Herpes Simplex Virus | p. 125 |
| Immunity to HSV Infection | p. 126 |
| Innate and Adaptive Immunity | p. 127 |
| Memory Cytotoxic T Lymphocytes | p. 128 |
| Psychological Stress and Immunity | p. 129 |
| Stress and the Innate Immune Response to HSV Infection | p. 130 |
| Inflammatory Response | p. 130 |
| Leukocyte Trafficking and Recruitment | p. 131 |
| Cells of the Innate Immune System | p. 132 |
| Stress and the Adaptive Immune Response to HSV Infection | p. 133 |
| Humoral Immunity | p. 133 |
| Cellular Immunity | p. 134 |
| The Impact of Stress on the Pathogenesis of HSV Infection | p. 136 |
| Introduction | p. 136 |
| The Impact of Stress on Primary HSV Infection | p. 136 |
| The Impact of Stress on HSV Reactivation and Recurrent HSV Infection | p. 138 |
| Human Studies | p. 138 |
| Animal Studies | p. 138 |
| The Impact of Stress on the Memory Immune Response to HSV Infection | p. 139 |
| The Role of Stress in Preventing HSV Infections | p. 140 |
| Concluding Remarks | p. 141 |
| References | p. 142 |
| Influenza Viral Infection: Stress-induced Modulation of Innate Resistance and Adaptive Immunity | p. 150 |
| Introduction | p. 150 |
| Immune Response to Influenza Viral Infection | p. 151 |
| Innate Immune Response to Influenza Virus (Type I Interferons) | p. 152 |
| Innate Immune Responses to Influenza Virus (Inflammation) | p. 152 |
| Cell-mediated Immune Responses to Influenza Virus | p. 154 |
| Immunological Memory to Influenza Virus | p. 155 |
| Memory B-Cell Response to Influenza Virus | p. 156 |
| Memory T-Cell Response to Influenza Virus | p. 157 |
| Stress and the Immune Response to Influenza Virus | p. 160 |
| Restraint Stress Suppresses the Immune Response to Infection with Influenza Virus | p. 162 |
| Stress-induced Effects on Innate Immune Responses to Infection with Influenza Virus | p. 162 |
| Stress-induced Effects on Adaptive Immunity to Infection with Influenza Virus | p. 165 |
| Restraint Stress and T-Cell Responses | p. 165 |
| Restraint Stress and B-Cell Responses | p. 166 |
| Social Disruption Stress, Glucocorticoid Resistance, and the Immune Response to an Influenza Viral Infection | p. 166 |
| Social Stress | p. 166 |
| SDR and LPS Challenge | p. 167 |
| SDR and Influenza Viral Infection | p. 168 |
| General Conclusions | p. 168 |
| References | p. 168 |
| Autonomic Nervous System Influences on HIV Pathogenesis | p. 176 |
| Introduction | p. 176 |
| Catecholamine Acceleration of HIV-1 Replication | p. 179 |
| Virologic Mechanisms | p. 179 |
| The Neuroanatomic Basis of ANS Interactions | p. 183 |
| Conclusion | p. 185 |
| References | p. 186 |
| The Effects of Restraint Stress on the Neuropathogenesis of Theiler's Virus-induced Demyelination: A Murine Model for Multiple Sclerosis | p. 190 |
| Introduction | p. 190 |
| Stress and the Immune System | p. 190 |
| Multiple Sclerosis | p. 191 |
| Stress and Multiple Sclerosis | p. 191 |
| A Viral Etiology for Multiple Sclerosis | p. 192 |
| Theiler's Virus-induced Demyelination as a Model for MS | p. 192 |
| Interferon and NK Cells in Theiler's Virus Infection | p. 193 |
| Role of CD8[superscript +] and CD4[superscript +] T Cells in Theiler's Virus Infection | p. 195 |
| Th1/Th2 Responses in TVID | p. 196 |
| Mechanisms of Theiler's Virus-induced Demyelination | p. 198 |
| Stress Effects on the Neuropathogenesis of Theiler's Virus Infection | p. 199 |
| General Restraint Procedures and Experimental Design | p. 199 |
| Mice | p. 199 |
| Virus | p. 199 |
| Restraint Stress Protocol | p. 199 |
| The Effects of Restraint Stress on Early Theiler's Virus Infection | p. 200 |
| Restraint Stress Alters Chemokine/Cytokine mRNA Expression | p. 204 |
| Restraint Stress Fails to Render TVID-Resistant Mice Susceptible to TVID | p. 205 |
| The Effects of Restraint Stress During Acute Infection on the Later Demyelinating Disease | p. 206 |
| The Effect of Restraint Stress During the Chronic Demyelinating Disease | p. 207 |
| Summary and Significance of Research Findings | p. 207 |
| References | p. 208 |
| Social Stress Alters the Severity of an Animal Model of Multiple Sclerosis | p. 216 |
| Introduction | p. 216 |
| Multiple Sclerosis | p. 216 |
| A Viral Etiology for MS | p. 217 |
| Animal Models of Virus-induced Demyelination | p. 217 |
| MS and Stress | p. 218 |
| Theiler's Virus Infection as a Model for MS | p. 219 |
| The Immune Response in TMEV Infection | p. 219 |
| Theiler's Virus-induced Demyelination (TVID) | p. 220 |
| Social Stress and Immunity | p. 220 |
| Social Stress, Immunity, and Glucocorticoid Resistance in Mice | p. 221 |
| Social Stress and Glucocorticoid Resistance in MS | p. 222 |
| The Effects of Social Stress on TMEV Infection | p. 223 |
| Effect of Social Stress During Acute TMEV Infection | p. 223 |
| Social Stress, GC Resistance, and Exacerbation of Acute TMEV | p. 226 |
| The Role of IL-6 in Mediating the Adverse Effects of Social Stress | p. 226 |
| Clinical Significance of Acute Social Stress Effects | p. 228 |
| Impact of Social Stress on Chronic TMEV Infection | p. 228 |
| Neonatal Experience Alters the Impact of Social Stress | p. 230 |
| General Conclusions | p. 231 |
| References | p. 232 |
| Early Postnatal Nongenetic Factors Modulate Disease Susceptibility in Adulthood: Examples from Disease Models of Multiple Sclerosis, Periodontitis, and Asthma | p. 241 |
| The Development of Nongenetic Acquired Individual Differences | p. 241 |
| Introduction | p. 241 |
| Stress and Adaptation | p. 241 |
| The Early Environment and Maternal Behavior in Rodents | p. 242 |
| Modulation of Disease Susceptibility by Early Experiences | p. 244 |
| Maternal Deprivation and Postnatal Handling Stimulation (Prolonged vs. Short Separation): Oppositional Paradigms of Early Deprivation and Stimulation | p. 244 |
| Individual Differences in Response to Ligature-induced Periodontitis | p. 246 |
| The Animal Model of Periodontitis | p. 246 |
| Different Effects of HA and MD Depend on Genetics | p. 246 |
| Amelioration of Disease Progress by Antidepressant Treatment | p. 247 |
| Asthma | p. 248 |
| Disease Model of Experimentally Induced Asthma Bronchiale | p. 248 |
| Differential Effects of HA and MD | p. 248 |
| Experimental Allergic Encephalomyelitis (EAE) | p. 250 |
| Disease Model of EAE | p. 250 |
| Imipramine as a Sufficient Treatment of MD-induced Aggravation of EAE | p. 250 |
| Early Life Stress Increases Disease Susceptibility in Adulthood | p. 251 |
| References | p. 252 |
| The Relationship Between Stressful Life Events and Inflammation Among Patients with Multiple Sclerosis | p. 255 |
| Introduction | p. 255 |
| Brief Review of MS Pathology and Pathogenesis | p. 255 |
| Evidence of the Relationship Between Stressful Life Events and MS Exacerbation | p. 257 |
| Laboratory Studies of Acute Stress Responses in MS | p. 258 |
| HPA | p. 259 |
| Immune Responses to Acute Psychological Stressors in MS | p. 260 |
| Three Hypotheses Regarding the Mechanisms by Which Stress Leads to Exacerbation | p. 261 |
| Stress Resolution Hypothesis | p. 262 |
| Development of Chronic Stress: Glucocorticoid Resistance | p. 263 |
| Stress Onset: The Mast Cell Hypothesis | p. 264 |
| Psychosocial Factors | p. 265 |
| Psychosocial Mediators | p. 266 |
| Psychosocial Moderators | p. 266 |
| Summary and Future Directions | p. 267 |
| References | p. 268 |
| Index | p. 275 |
| Table of Contents provided by Ingram. All Rights Reserved. |